The University of Southampton
University of Southampton Institutional Repository

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS
In this study, we investigate the expression of fractalkine (CX3CL1) and the fractalkine receptor (CX3CR1) in the naive rat and mouse central nervous system (CNS). We determine if the expression of this chemokine and its receptor are altered during chronic or acute inflammation in the CNS. In addition, we determine if CX3CL1, which has been reported to be chemoattractant to leukocytes in vitro, is capable of acting as a chemoattractant in the CNS in vivo. Immunohistochemistry was performed using primary antibodies recognizing soluble and membrane-bound CX3CL1 and the N-terminus of the CX3CR1. We found that neurons in the naive rodent brain are immunoreactive for CX3CL1 and CX3CR1, both showing a perinuclear staining pattern. Resident microglia associated with the parenchyma and macrophages in the meninges and choroid plexus constituitively express CX3CR1. In a prion model of chronic neurodegeneration and inflammation, CX3CL1 immunoreactivity is upregulated in astrocytes and CX3CR1 expression is elevated on microglia. In surviving neurons, expression of CX3CL1 appears unaltered relative to normal neurons. There is a decrease in neuronal CX3CR1 expression. Acute inflammatory responses in the CNS, induced by stereotaxic injections of lipopolysaccharide or kainic acid, results in activation of microglia and astrocytes but no detectable changes in the glial expression of CX3CL1 or CX3CR1. The expression of CX3CL1 and CX3CR1 by glial cells during inflammation in the CNS may be influenced by the surrounding cytokine milieu, which has been shown to differ in acute and chronic neuroinflammation.
chemokine, chemokine receptor, brain, in vivo, inflammation
0894-1491
314-327
Hughes, P.M.
cd487a39-4fd9-4ccd-8f2a-79751f682057
Botham, M.S.
55543099-594a-47fb-b5d5-549ab80a3d96
Frentzel, S.
d86c067f-8023-4cd5-a740-38c4822710c5
Mir, A.
1e726305-f811-4a03-ad26-c26fa7a6cdf4
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
Hughes, P.M.
cd487a39-4fd9-4ccd-8f2a-79751f682057
Botham, M.S.
55543099-594a-47fb-b5d5-549ab80a3d96
Frentzel, S.
d86c067f-8023-4cd5-a740-38c4822710c5
Mir, A.
1e726305-f811-4a03-ad26-c26fa7a6cdf4
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4

Hughes, P.M., Botham, M.S., Frentzel, S., Mir, A. and Perry, V.H. (2002) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. GLIA, 37 (4), 314-327. (doi:10.1002/glia.10037).

Record type: Article

Abstract

In this study, we investigate the expression of fractalkine (CX3CL1) and the fractalkine receptor (CX3CR1) in the naive rat and mouse central nervous system (CNS). We determine if the expression of this chemokine and its receptor are altered during chronic or acute inflammation in the CNS. In addition, we determine if CX3CL1, which has been reported to be chemoattractant to leukocytes in vitro, is capable of acting as a chemoattractant in the CNS in vivo. Immunohistochemistry was performed using primary antibodies recognizing soluble and membrane-bound CX3CL1 and the N-terminus of the CX3CR1. We found that neurons in the naive rodent brain are immunoreactive for CX3CL1 and CX3CR1, both showing a perinuclear staining pattern. Resident microglia associated with the parenchyma and macrophages in the meninges and choroid plexus constituitively express CX3CR1. In a prion model of chronic neurodegeneration and inflammation, CX3CL1 immunoreactivity is upregulated in astrocytes and CX3CR1 expression is elevated on microglia. In surviving neurons, expression of CX3CL1 appears unaltered relative to normal neurons. There is a decrease in neuronal CX3CR1 expression. Acute inflammatory responses in the CNS, induced by stereotaxic injections of lipopolysaccharide or kainic acid, results in activation of microglia and astrocytes but no detectable changes in the glial expression of CX3CL1 or CX3CR1. The expression of CX3CL1 and CX3CR1 by glial cells during inflammation in the CNS may be influenced by the surrounding cytokine milieu, which has been shown to differ in acute and chronic neuroinflammation.

This record has no associated files available for download.

More information

Published date: 4 February 2002
Keywords: chemokine, chemokine receptor, brain, in vivo, inflammation

Identifiers

Local EPrints ID: 56339
URI: http://eprints.soton.ac.uk/id/eprint/56339
ISSN: 0894-1491
PURE UUID: 83e0a5f7-cf5b-4edd-a3c1-cfc29347d0b8

Catalogue record

Date deposited: 08 Aug 2008
Last modified: 15 Mar 2024 11:01

Export record

Altmetrics

Contributors

Author: P.M. Hughes
Author: M.S. Botham
Author: S. Frentzel
Author: A. Mir
Author: V.H. Perry

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×